Clinical Trials Browser

Terminated × NIH × Denosumab × Clear all

NCT03382574 2022-06-14

Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-Oophorectomy

Phase EARLY_PHASE1 Terminated

Ovarian Neoplasms